Viking Therapeutics VKTX
NASDAQ VKTX
$28.44 -0.22 (-0.77%)
At close: Nov 11, 2026 · 4:00 PM EST

Viking Therapeutics (VKTX) Shares Repurchased (2022)

Updated

Viking Therapeutics (VKTX) reported Shares Repurchased of $6.8 million for FY2022.

Analysis

Viking Therapeutics (VKTX) Shares Repurchased (2022) Analysis & Trends

Dating back to FY2014, Viking Therapeutics' Shares Repurchased record includes 4 years.

  • The FY2022 figure ranks as the lowest annual Shares Repurchased since FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 653.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 370.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Viking Therapeutics 3.65 Bn 884.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 1.67 Mn
Mar 31, 2022 5.12 Mn
API Access

Viking Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=VKTX&period=max&api_key=YOUR_API_KEY